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Abstract
Background: As a risk factor of tuberculosis (TB), tobacco smoking has increased substantially
over the past three decades, especially in developing countries. However, the association between
smoking and TB, which has been shown to exist in different studies with different ethnic
background, has not yet received sufficient attention in terms of TB care standards and research in
China.
Methods: An observational study was conducted in two rural areas of China. A total of 613 TB
patients frequency matched with 1226 controls were interviewed by using a structured
questionnaire. The associations between cigarette smoking and risk of TB were estimated by
computing odds ratios (ORs) and 95% confidence intervals (95% CIs) from logistic regression
model. Patients' smoking behavior and patterns of smoking cessation were followed after TB
diagnosis. Multivariate Cox proportional hazards model was applied to calculate hazard ratios
(HRs) and 95% confidence intervals (95% CIs) in analyzing the risk factors for smoking relapse. The
Kaplan-Meier estimate was computed to plot the ability of smoking-free after cessation among
different groups, with the Log-rank test being used to compare the difference.
Results: The proportion of cigarette smoking was 54.6% in TB cases, which was significantly higher
than that in controls (45.1%) with adjusted OR of 1.93(95% CI: 1.51–2.48). Though 54.9% smokers
stopped smoking after being diagnosed with TB, more than 18% relapsed during the follow-up
period. The proportion of relapse was higher within 6–9 months (6%) and 12–15 months (11%)
after cessation. In the Cox regression estimates adjusted for age and gender, compared with those
highly educated and previously treated patients, the hazard ratios of smoking relapse were
3.48(95% CI: 1.28–9.47) for less educated (< 6 years) and 4.30(95% CI: 1.01–18.30) for newly
treated patients, respectively.
Conclusion: Cigarette smoking is associated with TB in the Chinese. Interventions of smoking
cessation are recommended to be included in the current TB control practice.
Background
Tuberculosis (TB) is one of the leading causes of death in
the world and remains a major public health burden in
many developing countries [1]. From worldwide epi-
demic of TB in 2006, around 9.2 million new cases and
1.7 million deaths were expected every year, of which 0.7
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million cases and 0.2 million deaths were in HIV-positive
people [2].
As a risk factor of TB, tobacco smoking has increased sub-
stantially over the past three decades, especially in devel-
oping countries [3,4]. Globally, TB and smoking are
simultaneously increasing, both of which could damage
the lungs, and interact at an immunologic and cellular
level [5]. Studies investigating the association between
smoking and TB have been published since 1918 [6]. Both
passive and active exposures to tobacco smoke have been
shown to be associated with TB infection and the transi-
tion from being infected to developing TB disease. More-
over, cigarette smoking is also associated with the
prognosis of TB. A cohort study conducted in Hong Kong
found that significantly more current smokers developed
TB and subsequently died within the follow-up period
than ex-smokers and never-smokers [7]. Thomas investi-
gated predictors of recurrence among TB patients in South
India and showed that a higher relapse rate was independ-
ently associated with smoking (OR: 3.1, 95% CI: 1.6–6.0)
[8].
However, the association between smoking and TB, which
has been shown to exist in different studies with different
ethnic background, has not yet received sufficient atten-
tion in terms of TB care standards and research. Though
both smoking and TB are targeted by major international
prevention and control efforts, there has been little
research on the measures and effects of smoking cessation
among TB patients [5].
In the present study, we aim to investigate the cigarette
smoking behavior among TB patients and smoking cessa-
tion after diagnosis, and to identify factors associated with
smoking relapse among quitters. It might be helpful to
provide policy directions on tobacco control for current
TB program.
Methods
Study design
As shown in Figure 1, a case-control study was conducted
to estimate the association between cigarette smoking and
risk of TB. Among current smokers, smoking cessation
behavior after TB diagnosis was observed and its correla-
tion to anti-tuberculosis treatment adherence was
explored.
Flow chart of the study design Figure 1
Flow chart of the study design.BMC Public Health 2009, 9:292 http://www.biomedcentral.com/1471-2458/9/292
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Study sites
This study was conducted in Yangzhong and Wujin
County, both of which were relatively rich rural areas,
located in the southeast part of Jiangsu Province, China.
The local TB dispensary was affiliated to the county Centre
for Disease Prevention and Control (CDC) which was for-
merly called Anti-Epidemic Station. All newly notified TB
patients were registered and managed under the DOTS
(directly observed therapy, short-course) program. The
annual notification rate of TB in 2007 was 79/100,000 in
Yangzhong and 78/100,000 in Wujin, respectively.
Study subjects
TB patients diagnosed in Yangzhong (905 cases from
2004 to 2007) and Wujin (1476 cases from 2006 to 2007)
were target population of this study. By using simple ran-
dom sampling method, 700 cases in each site were
selected and those with eligible phone numbers recorded
in the registry book were contacted by telephone. A total
of 613 patients, including 381 patients in Yangzhong and
232 patients in Wujin County, were successfully recruited
in this study. The reasons for non-response included
migration, death, and stopping or changing the phone
numbers, etc. To further explore the potential selection
bias in this study, we compared the distribution of key
characteristics between source population and these 613
cases. No significant difference was found on the distribu-
tion of gender and sputum smear test results (P > 0.05).
However, the average age of patients included in this
study was older than that of registered patients (56 ± 16
years vs. 50 ± 19 years). It might be attributed to the
higher migration rate among young patients. A total of
1226 controls were randomly selected from a pool of
more than 30,000 individuals (overall response rate:
86%) who participated in a community-based health
examination program conducted in Jiangsu Province dur-
ing the same time period as the cases were recruited [9].
These control subjects had no self-reported history of TB,
diabetes and malignancy and were frequency matched to
the cases on gender, age (± 5 years) and residential areas
(urban and rural). The cases and control subjects were all
genetically-unrelated Han Chinese.
Data collection
Based on the local TB management system, all patients
were followed up by TB dispensary for the whole treat-
ment episode. To further explore the role of cigarette
smoking in the risk of TB and to examine longitudinal
patterns of smoking cessation among TB patients, we fol-
lowed these patients again in March, 2008, by inviting
them to CDC for personal interview. The interview was
undertaken by trained investigators using a structured
questionnaire. To ensure that all items were correctly
filled in, the research supervisor double checked the ques-
tionnaires every day. For cigarette smoking status, a per-
son who smoked at least once a day and lasted for more
than 6 months in his or her lifetime was regarded as a
smoker. Ex-smoker (former smoker) was defined as a
smoker who had stopped smoking for at least 3 months.
Smoking relapse among TB patients was defined as those
who quitted smoking (≥ 3 months) after being diagnosed
with TB but smoked again in the follow-up period. For
alcohol drinking, it was defined as those who reported
drinking alcohol more than 3 times per week. Non-adher-
ence to anti-tuberculosis treatment was defined as those
who had interrupted treatment for more than 2 weeks,
including those who refused to take drugs or stopped
treatment for two weeks before the end of the prescribed
course.
Data analysis
Data were managed with EpiData 3.1 (Denmark) and
analyzed by STATA 10.0 (College station, TX, USA). Dif-
ferences in the distribution of demographic characteristics
(gender, age, education and marital status) and selected
variables (alcohol drinking history) between cases and
controls were tested by using the Student t-test (for con-
tinuous variables) or χ2-test (for categorical variables).
The associations between cigarette smoking and risk of TB
were estimated by computing odds ratios (ORs) and their
95% confidence intervals (CIs) using logistic regression
model. Crude odds ratios and corresponding adjusted
odds ratios by controlling age, gender and alcohol drink-
ing history for cigarette smoking history, age of starting
smoking, smoking years and cumulative pack-years were
calculated respectively. To evaluate the effects of cigarette
smoking on TB risk according to selected variables (gen-
der, age, education and alcohol drinking), stratified anal-
ysis was also performed. Multivariate Cox proportional
hazards model was applied to calculate hazard ratios
(HRs) and 95% confidence intervals (95% CIs) in analyz-
ing the risk factors for smoking relapse. The Kaplan-Meier
estimate was computed to plot the ability of smoking-free
after cessation among different groups, with the Log-rank
test being used to compare the difference. During the fol-
low-up period, if the quitter smoked again, it was defined
as one event in the model; otherwise it was regarded as the
censor. The criterion for significance was set at P < 0.05
based on a two-sided test. The continuous variables of age,
age of starting smoking, smoking years, cigarettes per day
and cumulative pack-year were transferred to categories by
using median among controls as cutoff point.
Ethical consideration
This project has been approved by Institutional Review
Board of Nanjing Medical University. Written informed
consent was obtained from all participants. Ethics has
been respected throughout the whole study period.BMC Public Health 2009, 9:292 http://www.biomedcentral.com/1471-2458/9/292
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Results
Cigarette smoking and risk of TB
A total of 613 patients (men 458, women 155) and 1226
healthy controls (men 916, women 310) were included in
the analysis. The average age (mean ± SD) was 56.0 ± 16.5
years among cases and 56.0 ± 16.4 years among controls,
respectively. As a result of frequency-matching, there were
no significant differences in the distribution of gender and
age between cases and controls (Table 1). The proportion
of smokers was 54.6% in TB cases, which was significantly
higher than that in controls (45.1%) with the crude OR of
1.47 (95% CI: 1.21–1.78). After adjusting for gender, age
and alcohol drinking history, the OR was 1.93 (95% CI:
1.51–2.48). For former and current smokers, the adjusted
ORs were 1.95 (95% CI: 1.32–2.87) and 1.93 (95% CI:
1.49–2.49), respectively. Both of the cumulative smoking
years and amount of cigarette consumption were associ-
ated with a significantly increased risk of TB. Compared
with nonsmokers, the ORs were 1.73(95% CI: 1.30–2.31)
and 2.18(95% CI: 1.63–2.91) for those with cumulative
pack-year less than 29 and over 29, respectively. Individu-
als who started smoking earlier than 25-year-old had
higher risk than those who started smoking later, with the
ORs of 2.09(95% CI: 1.59–2.75) and 1.72(95% CI: 1.28–
2.33), respectively (Table 2). To evaluate the effects of cig-
arette smoking on TB risk according to selected variables,
we further performed stratified analyses. As shown in
Table 3, the increased risk of TB associated with smoking
was more evident among the older adults (age ≥ 56 years)
(OR: 2.56, 95% CI: 1.84–3.56), less educated individuals
(< 6 years) (OR: 2.23, 95% CI: 1.56–3.17) and people
with alcohol drinking history (OR: 2.45, 95% CI: 1.48–
4.06).
Smoking cessation and treatment adherence
A total of 277 patients were current smokers at the time of
diagnosis and 152 quitted smoking after being diagnosed
with TB. Among those who did not stop smoking, 19.5%
reported non-adherence during the treatment period,
which was higher than that among quitters (11.3%) and
non-smokers (15.0%). After adjusting for age, gender and
alcohol drinking history, the risk for non-adherence was
increased among patients without smoking cessation
(OR: 2.03, 95% CI: 0.99–4.18).
Factors associated with smoking relapse
Though 54.9% smokers stopped smoking after being
diagnosed with TB, more than 18% of quitters relapsed
again during the follow-up period (the mean duration of
follow-up was 1.35 years, ranging from 3 months to 49
months). The proportions of smoking relapse were 0,
0.01, 0.06, 0.02 and 0.11 at the time period of 0–3, 3–6,
6–9, 9–12 and 12–15 months, respectively. The Kaplan-
Meier survival estimates for smoking-free after cessation
among patients with different treatment history and edu-
cation level were shown in Figure 2 (Log-rank test: P =
0.042) and Figure 3 (Log-rank test: P = 0.002), respec-
tively. In the Cox regression estimates adjusted for age and
gender, compared with those highly educated and previ-
ously treated patients, the hazard ratios of smoking
relapse were 3.48 (95% CI: 1.28–9.47) for less educated
Table 1: Basic characteristics of cases and controls
Variables Case(n = 613) n(%) Control(n = 1226) n(%) P Value
Gender
Men 458(74.7) 916(74.7) 1.000†
Women 155(25.3) 310(25.3)
Age (years)
Mean ± SD 56.0 ± 16.5 56.0 ± 16.4 0.963‡
< 56 270(44.0) 545(44.5) 0.868†
≥ 56 343(56.0) 681(55.5)
Education(years)
< 6 309(50.4) 675(55.1) 0.060†
≥ 6 304(49.6) 551(44.9)
Marital status
Single 32(5.2) 54(4.4) 0.175†
Married 537(87.6) 1054(86.0)
Divorced/widowed 44(7.2) 118(9.6)
Alcohol drinking
Never 450(73.4) 839(68.4) 0.028†
Ever 163(26.6) 387(31.6)
Sputum smear test*
Negative 274(45.1)
Positive 334(54.9)
†: Chi-square test; ‡: Student t-test; *Five patients without sputum smear test resultsBMC Public Health 2009, 9:292 http://www.biomedcentral.com/1471-2458/9/292
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Table 2: Association between tuberculosis and cigarette smoking
Variables Case(n = 613) n(%) Control(n = 1226) n(%) cOR(95% CI)† aOR(95% CI)‡
Cigarette smoking
Never 278(45.4) 673(54.9) Ref. Ref.
Ever 335(54.6) 553(45.1) 1.47(1.21–1.78) 1.93(1.51–2.48)
Former 58(9.5) 93(7.6) 1.51(1.06–2.16) 1.95(1.32–2.87)
Current 277(45.2) 460(37.5) 1.46(1.19–1.79) 1.93(1.49–2.49)
Age of starting smoking (years)
Never 278(45.4) 673(54.9) Ref. Ref.
< 25 209(34.1) 325(26.5) 1.56(1.25–1.95) 2.09(1.59–2.75)
≥ 25 126(20.5) 228(18.6) 1.34(1.03–1.73) 1.72(1.28–2.33)
Smoking years
Never 278(45.4) 673(54.9) Ref. Ref.
< 30 135(22.0) 256(20.9) 1.28(0.99–1.64) 1.62(1.19–2.19)
≥ 30 200(32.6) 297(24.2) 1.63(1.30–2.05) 2.23(1.68–2.97)
Cigarettes per day
Never 278(45.4) 673(54.9) Ref. Ref.
< 19 107(17.5) 204(16.6) 1.27(0.97–1.67) 1.67(1.22–2.29)
≥ 19 228(37.2) 349(28.5) 1.58(1.27–1.97) 2.08(1.59–2.72)
Cumulative pack-years
Never 278(45.4) 673(54.9) Ref. Ref.
< 29 164(26.8) 299(24.4) 1.33(1.05–1.68) 1.73(1.30–2.31)
≥ 29 171(27.9) 254(20.7) 1.63(1.28–2.07) 2.18(1.63–2.91)
†cOR: crude odds ratio; ‡aOR: adjusted odds ratio, adjusting for age, gender and alcohol drinking history
Table 3: Stratified analysis on the association between cigarette smoking and tuberculosis by selected factors
Stratified variables Smoking Case(n = 613) n(%) Control(n = 1226) n(%) aOR(95% CI)†
Gender
Men Never 125(27.3) 366(40.0) Ref.
Ever 333(72.7) 550(60.0) 1.93(1.50–2.48)
Women Never 153(98.7) 307(99.0) Ref.
Ever 2(1.3) 3(1.0) 2.06(0.30–14.28)
Age (years)
< 56 Never 148(54.8) 310(56.9) Ref.
Ever 122(45.2) 235(43.1) 1.28(0.87–1.89)
≥ 56 Never 130(37.9) 363(53.3) Ref.
Ever 213(62.1) 318(46.7) 2.56(1.84–3.56)
Education (years)
< 6 Never 142(46.0) 385(57.0) Ref.
Ever 167(54.0) 290(43.0) 2.23(1.56–3.17)
≥ 6 Never 136(44.7) 288(52.3) Ref.
Ever 168(55.3) 263(47.7) 1.68(1.18–2.38)
Alcohol drinking
Never Never 255(56.7) 560(66.7) Ref.
Ever 195(43.3) 279(33.3) 1.78(1.33–2.38)
Ever Never 23(14.1) 113(29.2) Ref.
Ever 140(85.9) 274(70.8) 2.45(1.48–4.06)
†aOR: adjusted odds ratio, adjusting for age, gender and alcohol drinking history where appropriateBMC Public Health 2009, 9:292 http://www.biomedcentral.com/1471-2458/9/292
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Table 4: Factors associated with smoking relapse
Variables Total quitters(n) Relapse(n) HR(95% CI)* P Value
Gender
Men 151 28 -
Women 1 0 -
Age (years)
< 56 54 5 Ref. 0.779
≥ 56 98 23 1.18(0.38–3.64)
Treatment history
Previously treated 25 2 Ref. 0.048
Newly treated 127 26 4.30(1.01–18.30)
Education (years)
≥ 68 3 7 R e f . 0 . 0 1 4
< 6 69 21 3.48(1.28–9.47)
*HR: adjusted hazard ratio, adjusting for age, gender, treatment history and education where appropriate
Kaplan-Meier survival estimates for patients with different treatment history in the risk of smoking relapse Figure 2
Kaplan-Meier survival estimates for patients with different treatment history in the risk of smoking relapse.BMC Public Health 2009, 9:292 http://www.biomedcentral.com/1471-2458/9/292
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(< 6 years) and 4.30 (95% CI: 1.01–18.30) for newly
treated patients, respectively (Table 4).
Discussion
Apart from HIV/AIDS, tobacco smoking is the only major
cause of death that is increasing rapidly [10]. It is esti-
mated that smoking will cause about 10 million adult
deaths from all causes in 2030 and most of the increased
tobacco-related deaths will take place in Asia, Africa and
South America [10]. China has the largest production and
consumption of tobacco worldwide [11]. Although the
government has announced its decision to ratify the
WHO's Framework Convention on Tobacco Control and
series of measures have already been taken, it is still at the
beginning of its 'long way' towards improving the popu-
lation's health status by reducing tobacco consumption in
China [12].
Tobacco contains more than 4,500 compounds in the par-
ticulate and vapor phases which comprise five known
human carcinogens and many toxic agents [13]. Long-
term inhalation of tobacco smoke alters a wide range of
immunological functions, resulting in significantly
increased risk of heart disease, lung cancer, microbial
infections and delayed recovery from these diseases [13].
Though the underlying biological mechanism is unclear,
strong associations between tobacco smoking and TB
have been proved in several areas [14]. Results from our
study also corroborated these former reports. Further-
more, a dose-response relationship between cigarette
smoking and TB was also demonstrated in the present
study: with the increase of daily cigarettes consumption
and duration of smoking, the risk for TB also increased
accordingly.
Given that smoking is indeed causally associated with TB
disease, the clinical manifestations could also be influ-
enced by the underlying mechanism of its action [15]. A
cohort of newly diagnosed TB cases were followed up
from their discharge after completion of treatment and it
was found that smoking was associated with the relapse of
TB with OR of 2.53 (95% CI: 1.23–5.21), even after
adjustment for the socioeconomic variables [16].
Although there is lack of evidence on the direct effects of
smoking cessation on TB treatment outcomes, available
data suggest that smokers are less adherent to TB treat-
ment, and thus at higher risk for default and persistent
infectivity [5,17]. In the present study, we also found that
patients without smoking cessation had higher risk for
non-adherence to anti-tuberculosis treatment. Non-
Kaplan-Meier survival estimates for patients with different education level in the risk of smoking relapse Figure 3
Kaplan-Meier survival estimates for patients with different education level in the risk of smoking relapse.BMC Public Health 2009, 9:292 http://www.biomedcentral.com/1471-2458/9/292
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adherence has been proved in several studies to contribute
to prolonged infectiousness, drug resistance, relapse and
death [18]. Thus, intervention for tobacco smoking is not
only a public health issue among general population, but
also an essential activity in TB control program.
It should be noticed that behavior of tobacco use is very
difficult to change, even with medicinal aids for cessation.
Only a small proportion of smokers stop smoking suc-
cessfully on their own [19]. Thus smoking cessation sup-
port should be incorporated with TB control programs. As
attitudes and knowledge can change, change of smoking
behaviors needs to be reinforced regularly. Repeated brief
cessation advice has been shown to be a feasible and inex-
pensive addition to routine TB case management [20].
Thus, offering advice to TB patients when they seek
healthcare can influence unhealthy behaviors. The central
strategy recommended by WHO for controlling TB is
DOTS. However, smoking cessation has not been
involved in the DOTS framework in China. TB patients
lack access to smoking intervention services and social
supports, resulting in lower cessation and higher relapse
rate. It is essential to revise current TB treatment guide-
lines and provide regular medical advice on smoking
behaviors involved in standard practice of DOTS and
other TB control programs. However, additional research
is needed in the form of pilot study to determine the fea-
sibility of this intervention, random controlled study to
test methods in various settings, and evaluation study to
determine effects after widespread application of such
practices [21].
One intriguing finding from the present study was that the
higher risk of smoking relapse occurred in the period of
6–9 months and 12–15 months after diagnosis. It might
be related with the traditional anti-tuberculosis treatment
period and patient's recovery from disease. Thus interven-
tions on smoking cessation should be focused on such
special risk periods.
There are several potential limitations of this study.
Firstly, our findings are based on the results of observa-
tional investigations. Though we have performed multi-
variate regression model and stratified analyses to control
the potential confounders, other factors including eco-
nomic status, intensive contact with TB patients, nutrition
intake, as well as exposure to other's smoke may also con-
found the association between smoking and TB. Secondly,
we enrolled TB patients with phone number and inter-
viewed those who were successfully contacted through tel-
ephone. Selection bias should not be neglected. Thirdly,
recall bias would also influence the results. Compared
with healthy controls, TB patients could attribute disease
to smoking and aggrandized it, resulting in the overesti-
mate of smoking effects. Fourthly, a major limitation of
this study was that smoking status was based on the
patient's self-report rather than the detection results of
nicotine levels. On one hand, some patients may decline
to admit to smoking, especially if a connection between
the disease and smoking has been accepted by people in
the community, which will underestimate the relation
between cigarette smoking and TB. On the other hand, TB
patients would be more likely to falsely admit to quitting
smoking for fear of disappointing the interviewers, result-
ing in the overestimate of smoking cessation proportion
among TB patients.
Conclusion
Cigarette smoking is associated with TB in the Chinese.
Interventions of smoking cessation among patients were
insufficient in rural areas of China. Physicians and DOTS
providers should be actively involved in smoking cessa-
tion activities. Regular and repeated medical advices on
smoking behaviors are recommended to be included in
DOTS practice.
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